Cargando…
Emerging immunotherapy targets in lung cancer
Immunotherapy has become the mainstay for lung cancer treatment, providing sustained therapeutic responses and improved prognosis compared with those obtained with surgery, chemotherapy, radiotherapy, and targeted therapy. It has the potential for anti-tumor treatment and killing tumor cells by acti...
Autores principales: | Zhu, Hao-Hua, Feng, Yu, Hu, Xing-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575190/ https://www.ncbi.nlm.nih.gov/pubmed/32947361 http://dx.doi.org/10.1097/CM9.0000000000001082 |
Ejemplares similares
-
Emerging Targets of Immunotherapy in Gynecologic Cancer
por: Cheng, Hongyan, et al.
Publicado: (2020) -
New emerging targets in cancer immunotherapy: the role of VISTA
por: Tagliamento, Marco, et al.
Publicado: (2020) -
New emerging targets in cancer immunotherapy: the role of neoantigens
por: De Mattos-Arruda, Leticia, et al.
Publicado: (2020) -
New emerging targets in cancer immunotherapy: the role of GITR
por: Buzzatti, Giulia, et al.
Publicado: (2020) -
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
por: Liu, Tongyan, et al.
Publicado: (2019)